| Fish oil prevents the adrenal activation elicited by mental stress in healthy men J Delarue, O Matzinger, C Binnert, P Schneiter, R Chiolero, L Tappy Diabetes & metabolism 29 (3), 289-295, 2003 | 226 | 2003 |
| EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach O Matzinger, E Gerber, Z Bernstein, P Maingon, K Haustermans, ... Radiotherapy and Oncology 92 (2), 164-175, 2009 | 154 | 2009 |
| Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925) O Matzinger, I Heimsoth, P Poortmans, L Collette, H Struikmans, ... Acta Oncologica 49 (1), 24-34, 2010 | 129 | 2010 |
| Acute toxicity of curative radiotherapy for intermediate-and high-risk localised prostate cancer in the EORTC trial 22991 O Matzinger, F Duclos, A Van den Bergh, C Carrie, S Villà, P Kitsios, ... European journal of cancer 45 (16), 2825-2834, 2009 | 117 | 2009 |
| Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study M Ozsahin, G Gruber, O Olszyk, O Karakoyun-Celik, B Pehlivan, D Azria, ... International Journal of Radiation Oncology* Biology* Physics 78 (4), 992-997, 2010 | 109 | 2010 |
| Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension A Zouhair, D Azria, P Coucke, O Matzinger, L Bron, R Moeckli, HP Do, ... Strahlentherapie und Onkologie 180 (2), 84, 2004 | 88 | 2004 |
| Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and … A Joosten, O Matzinger, W Jeanneret-Sozzi, F Bochud, R Moeckli Radiotherapy and Oncology 106 (1), 33-41, 2013 | 86 | 2013 |
| Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment … O Matzinger, F Roelofsen, L Mineur, S Koswig, ... European journal of cancer 45 (16), 2782-2791, 2009 | 72 | 2009 |
| The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma O Matzinger, D Viertl, P Tsoutsou, L Kadi, S Rigotti, C Zanna, ... Radiotherapy and Oncology 116 (3), 495-503, 2015 | 64 | 2015 |
| Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review O Matzinger, P Poortmans, JY Giraud, P Maingon, T Budiharto, ... Radiotherapy and Oncology 90 (3), 285-290, 2009 | 61 | 2009 |
| Volumetric‐modulated arc therapy planning using multicriteria optimization for localized prostate cancer S Ghandour, O Matzinger, M Pachoud Journal of applied clinical medical physics 16 (3), 258-269, 2015 | 50 | 2015 |
| Impact of induction therapy on airway complications after sleeve lobectomy for lung cancer M Gonzalez, Y Litzistorf, T Krueger, SG Popeskou, O Matzinger, HB Ris, ... The Annals of thoracic surgery 96 (1), 247-252, 2013 | 41 | 2013 |
| Radiochemotherapy in locally advanced squamous cell carcinomas of the head and neck O Matzinger, A Zouhair, RO Mirimanoff, M Ozsahin Clinical Oncology 21 (7), 525-531, 2009 | 38 | 2009 |
| EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility A Fairchild, E Aird, PA Fenton, V Gregoire, A Gulyban, D Lacombe, ... Radiotherapy and Oncology 103 (3), 279-286, 2012 | 36 | 2012 |
| Irinotecan-induced interstitial pneumonia O Michielin, E Udry, D Periard, O Matzinger, JA Lobrinus, R Stupp The lancet oncology 5 (5), 322-324, 2004 | 32 | 2004 |
| A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives V Achard, DM Aebersold, AS Allal, N Andratschke, BG Baumert, KT Beer, ... Radiotherapy and Oncology 150, 1-3, 2020 | 31 | 2020 |
| Locoregional control and toxicity in head and neck carcinoma patients following helical Tomotherapy-delivered intensity-modulated radiation therapy compared with 3D-CRT data O Santa Cruz, P Tsoutsou, C Castella, K Khanfir, S Anchisi, S Bouayed, ... Oncology 95 (2), 61-68, 2018 | 29 | 2018 |
| Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy M Ozsahin, M Betz, O Matzinger, L Bron, F Luthi, P Pasche, D Azria, ... Archives of Otolaryngology–Head & Neck Surgery 132 (2), 141-145, 2006 | 29 | 2006 |
| Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization? J Delaloye, G Merlani, C Petignat, A Wenger, K Zaman, C Monnerat, ... European Journal of Clinical Microbiology and Infectious Diseases 23, 751-758, 2004 | 28 | 2004 |
| Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate-and high-risk prostate cancer P Ghadjar, O Matzinger, B Isaak, F Behrensmeier, A Stroux, CA Rentsch, ... Radiotherapy and Oncology 91 (2), 237-242, 2009 | 27 | 2009 |
Akos GulybanMedical physicist, Jules Bordet InstituteVerified email at bordet.be
